These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 28125398)

  • 21. Cethromycin-mediated protection against the plague pathogen Yersinia pestis in a rat model of infection and comparison with levofloxacin.
    Rosenzweig JA; Brackman SM; Kirtley ML; Sha J; Erova TE; Yeager LA; Peterson JW; Xu ZQ; Chopra AK
    Antimicrob Agents Chemother; 2011 Nov; 55(11):5034-42. PubMed ID: 21859946
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Animal Exposure and Human Plague, United States, 1970-2017.
    Campbell SB; Nelson CA; Hinckley AF; Kugeler KJ
    Emerg Infect Dis; 2019 Dec; 25(12):2270-2273. PubMed ID: 31742515
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ciprofloxacin prophylaxis and therapy of Yersinia pestis infection.
    Shah PM
    J Antimicrob Chemother; 1998 Sep; 42(3):399. PubMed ID: 9786484
    [No Abstract]   [Full Text] [Related]  

  • 24. [Lack of levofloxacin and moxyfloxacin efficacy in experimental plague of albino mice infected with nalidixic acid resistant pathogen (Nal(r))].
    Ryzhko IV; Trishina AV; Verkina LM
    Antibiot Khimioter; 2010; 55(11-12):22-4. PubMed ID: 21574421
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Gepotidacin is efficacious in a nonhuman primate model of pneumonic plague.
    Jakielaszek C; Hossain M; Qian L; Fishman C; Widdowson K; Hilliard JJ; Mannino F; Raychaudhuri A; Carniel E; Demons S; Heine HS; Hershfield J; Russo R; Mega WM; Revelli D; O'Dwyer K
    Sci Transl Med; 2022 Jun; 14(647):eabg1787. PubMed ID: 35648812
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In vitro efficacy of antibiotics commonly used to treat human plague against intracellular Yersinia pestis.
    Wendte JM; Ponnusamy D; Reiber D; Blair JL; Clinkenbeard KD
    Antimicrob Agents Chemother; 2011 Aug; 55(8):3752-7. PubMed ID: 21628541
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Evaluation of the effectiveness of antibacterial substances in treating an experimental form of bubonic plague in monkeys].
    Romanov VE; Evstigneev VI; Vasil'ev NT; Shabalin BA; Paramonov VE
    Antibiot Khimioter; 2001; 46(8):6-8. PubMed ID: 11871319
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [The resurgence of the plague].
    Le Guern AS; Carniel É
    Rev Prat; 2016 Apr; 66(4):413-418. PubMed ID: 30512706
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Treatment of Human Plague: A Systematic Review of Published Aggregate Data on Antimicrobial Efficacy, 1939-2019.
    Godfred-Cato S; Cooley KM; Fleck-Derderian S; Becksted HA; Russell Z; Meaney-Delman D; Mead PS; Nelson CA
    Clin Infect Dis; 2020 May; 70(70 Suppl 1):S11-S19. PubMed ID: 32435800
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficacy of ciprofloxacin-gentamicin combination therapy in murine bubonic plague.
    Lemaître N; Ricard I; Pradel E; Foligné B; Courcol R; Simonet M; Sebbane F
    PLoS One; 2012; 7(12):e52503. PubMed ID: 23285069
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Transmission of Antimicrobial Resistant Yersinia pestis During a Pneumonic Plague Outbreak.
    Andrianaivoarimanana V; Wagner DM; Birdsell DN; Nikolay B; Rakotoarimanana F; Randriantseheno LN; Vogler AJ; Sahl JW; Hall CM; Somprasong N; Cauchemez S; Schweizer HP; Razafimandimby H; Rogier C; Rajerison M
    Clin Infect Dis; 2022 Mar; 74(4):695-702. PubMed ID: 34244722
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Postexposure Administration of a Yersinia pestis Live Vaccine for Potentiation of Second-Line Antibiotic Treatment Against Pneumonic Plague.
    Zauberman A; Gur D; Levy Y; Aftalion M; Vagima Y; Tidhar A; Chitlaru T; Mamroud E
    J Infect Dis; 2019 Aug; 220(7):1147-1151. PubMed ID: 31095689
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Use of an in vitro pharmacodynamic model to derive a moxifloxacin regimen that optimizes kill of Yersinia pestis and prevents emergence of resistance.
    Louie A; Heine HS; VanScoy B; Eichas A; Files K; Fikes S; Brown DL; Liu W; Kinzig-Schippers M; Sörgel F; Drusano GL
    Antimicrob Agents Chemother; 2011 Feb; 55(2):822-30. PubMed ID: 21115791
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Plague pneumonia disease caused by Yersinia pestis.
    Cleri DJ; Vernaleo JR; Lombardi LJ; Rabbat MS; Mathew A; Marton R; Reyelt MC
    Semin Respir Infect; 1997 Mar; 12(1):12-23. PubMed ID: 9097371
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Yersinia pestis infection in dogs: 62 cases (2003-2011).
    Nichols MC; Ettestad PJ; Vinhatton ES; Melman SD; Onischuk L; Pierce EA; Aragon AS
    J Am Vet Med Assoc; 2014 May; 244(10):1176-80. PubMed ID: 24786165
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cases of cat-associated human plague in the Western US, 1977-1998.
    Gage KL; Dennis DT; Orloski KA; Ettestad P; Brown TL; Reynolds PJ; Pape WJ; Fritz CL; Carter LG; Stein JD
    Clin Infect Dis; 2000 Jun; 30(6):893-900. PubMed ID: 10852811
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Epidemiological characteristics of an urban plague epidemic in Madagascar, August-November, 2017: an outbreak report.
    Randremanana R; Andrianaivoarimanana V; Nikolay B; Ramasindrazana B; Paireau J; Ten Bosch QA; Rakotondramanga JM; Rahajandraibe S; Rahelinirina S; Rakotomanana F; Rakotoarimanana FM; Randriamampionona LB; Razafimbia V; De Dieu Randria MJ; Raberahona M; Mikaty G; Le Guern AS; Rakotonjanabelo LA; Ndiaye CF; Rasolofo V; Bertherat E; Ratsitorahina M; Cauchemez S; Baril L; Spiegel A; Rajerison M
    Lancet Infect Dis; 2019 May; 19(5):537-545. PubMed ID: 30930106
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antimicrobial Treatment of Human Plague: A Systematic Review of the Literature on Individual Cases, 1937-2019.
    Nelson CA; Fleck-Derderian S; Cooley KM; Meaney-Delman D; Becksted HA; Russell Z; Renaud B; Bertherat E; Mead PS
    Clin Infect Dis; 2020 May; 70(70 Suppl 1):S3-S10. PubMed ID: 32435802
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pneumonic plague cluster, Uganda, 2004.
    Begier EM; Asiki G; Anywaine Z; Yockey B; Schriefer ME; Aleti P; Ogden-Odoi A; Staples JE; Sexton C; Bearden SW; Kool JL
    Emerg Infect Dis; 2006 Mar; 12(3):460-7. PubMed ID: 16704785
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Deaths Associated with Pneumonic Plague, 1946-2017.
    Salam AP; Rojek A; Cai E; Raberahona M; Horby P
    Emerg Infect Dis; 2020 Oct; 26(10):2432-2434. PubMed ID: 32946734
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.